Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs?

C Baudouin1

  • 1Department of Ophthalmology, Ambroise Paré Hospital, University of Paris-Ouest, Boulogne, France.

International Journal of Clinical Pharmacology Research
|January 1, 1996
PubMed

Insights

Glaucoma surgery success may decrease with prolonged use of antiglaucoma drugs. Preservatives like benzalkonium chloride in these eye drops may cause inflammation and reduce surgical outcomes.

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Drug Toxicology

Background:

  • Filtering glaucoma surgery effectiveness is increasingly questioned.
  • Preoperative use of antiglaucoma medications is a significant risk factor for surgical failure.
  • Chronic topical treatments can cause corneoconjunctival toxicity and inflammation.

Purpose of the Study:

  • To investigate the impact of antiglaucoma drug usage on filtering glaucoma surgery outcomes.
  • To identify the role of topical drug toxicity and inflammation in surgical failure.
  • To highlight the potential contribution of preservatives to adverse effects.

Main Methods:

  • Review of experimental and epidemiological studies on glaucoma surgery.
  • Histopathological examination of corneoconjunctival tissues from patients using antiglaucoma medications.
  • Analysis of risk factors associated with reduced surgical success rates.

Main Results:

  • Extended duration and higher number of antiglaucoma drugs significantly decrease success rates.
  • Topical antiglaucoma treatments induce chronic inflammation and toxic effects on the eye surface.
  • Benzalkonium chloride, a common preservative, shows strong evidence of toxicity.

Conclusions:

  • Antiglaucoma drug toxicity and inflammation are critical factors affecting filtering glaucoma surgery success.
  • Reducing or eliminating preservatives like benzalkonium chloride in eye drops is crucial for future treatments.
  • Further investigation into preservative-free antiglaucoma formulations is warranted.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...